Evidence map›Paper›PMID 39574651›Full record

ArticlebioRxiv : the preprint server for biology2024

Lrp1 facilitates infection of neurons by Jamestown Canyon virus.

Zachary D Frey, David A Price, Kaleigh A Connors, Rachael E Rush, Griffin Brown, Cade E Sterling, Farheen Fatma, Madeline M Schwarz, Safder Ganaie, Xiaoxia Cui and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Zachary D FreyCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
David A PriceDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Kaleigh A ConnorsCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Rachael E RushCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Griffin BrownDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.
Cade E SterlingCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Farheen FatmaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.
Madeline M SchwarzCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Safder GanaieDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.
Xiaoxia CuiGenome Engineering and Stem Cell Center (GEiC), Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States.
Zachary P WillsDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Daisy W LeungDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Gaya K AmarasingheDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.
Amy L HartmanCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.ORCID 0000-0002-0857-2973

Funding

Practices CoreUC7AI180311 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI William Paul Duprex · 2023 to 2026
$13.2M
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and PathogenesisR01AI161765 · NIAID · WASHINGTON UNIVERSITY · PI AMARASINGHE, GAYA K., HARTMAN, AMY L · 2021 to 2025
$3.7M
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyavirusesR01AI169850 · NIAID · WASHINGTON UNIVERSITY · PI Gaya K. Amarasinghe, Amy L Hartman · 2023 to 2026
$3.1M
Mechanisms of Neuronal Infection by Prototype Emerging BunyavirusesR01AI178378 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Amy L Hartman · 2023 to 2026
$3.0M
Neuroprotective anti-inflammatory drugs as a novel combination therapy for neurological Rift Valley FeverR01NS101100 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARTMAN, AMY L · 2017 to 2021
$1.7M
Comparative Analysis of Bunyavirus NeuropathogenesisR56AI171920 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARTMAN, AMY L · 2022 to 2022
$1.1M
NIAID NIH HHS R01 AI161765NIAID NIH HHS R01 AI169850NIAID NIH HHS R01 AI178378NIAID NIH HHS R56 AI171920NIAID NIH HHS UC7 AI180311NINDS NIH HHS R01 NS101100
6 · The paper itself

Abstract

Jamestown Canyon virus (JCV) is a bunyavirus and arbovirus responsible for neuroinvasive disease in the United States. Little is known about JCV pathogenesis, and no host factors required for cellular infection have been identified. Recently, we identified low-density lipoprotein receptor related protein 1 (Lrp1) as a host entry factor for two other bunyaviruses Rift Valley fever virus (RVFV) and Oropouche virus (OROV). Here, we assessed the role of Lrp1 in mediating JCV cellular infection of neurons. Both neuronal and non-neuronal immortalized cell lines deficient for Lrp1 displayed reduction in infection with JCV, and early stages of infection such as binding and internalization were impacted by lack of Lrp1. In primary rat neurons, Lrp1 was highly expressed, and the neurons were highly permissive for JCV infection. Treatment of primary neurons with recombinant receptor-associated protein (RAP), a high affinity ligand for Lrp1, resulted in reduced infectivity with JCV. In addition, pretreatment of cells with RVFV Gn inhibited JCV infection, suggesting that the two viruses may share overlapping binding sites. These results provide compelling evidence that Lrp1 is an important cellular factor for efficient infection by JCV, and thus multiple bunyaviruses with varying clinical manifestations and tissue tropism are facilitated by the host cell Lrp1. Reliance of multiple bunyaviruses on Lrp1 makes it a promising target for pan-bunyaviral antivirals and therapeutics.

Indexed as

bunyavirusCD91host factorJamestown Canyon virusLRP1primary rat neurons

Identifiers

PMID39574651
PMCPMC11580904

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.